ArticlePloS one2014

Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study.

Cheryl A London et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.